GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: CA
Buy $33

Ca Inc. (NASDAQ: CA) upgraded to Buy with price target $33 by Standpoint Research

Wednesday,  Nov 18, 2015  10:25 AM ET by Kristen Bailey

Standpoint Research upgraded Ca Inc. (NASDAQ: CA) to Buy with
price target $33. Standpoint Research rated Ca Inc. (NASDAQ: CA) to Hold on 03/19/2015, when the price was $32.33.

Careside has developed and plans to sell a proprietary blood testing systemcalled the Careside system. It is designed to decentralize laboratoryoperations. The system consists of a testing instrument called the CareSideAnalyzer and disposable test cartridges. It performs blood tests in the same location as the patient, or what is commonly called point-of-care testing. The company's goal is to make decentralized testing with the Careside system the standard for routine and critical care blood testing.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy